It is July 2021 and more than 4 million people across the world have lost their lives to Covid-19. With the pandemic still raging, mass vaccination programmes have been rolled out in many countries as one essential strategy to combat the virus. However, access to vaccines is highly uneven around the globe: while rich countries have vaccinated large proportions of their populations, some low-income countries have vaccination rates of under 1%. 

In this multi-issue, multi-party negotiation role play, participants representing governments from the Global North, governments from the Global South, and pharmaceutical companies and manufacturers must work together to improve access to vaccinations. And although all parties share a common interest in seeing vaccination rates rise globally, individual and national interests diverge and finding an agreement on the best route to achieve the desired goal is extremely challenging. In the negotiation, participants must navigate shifting alliances and competing interests and must, fundamentally, develop an understanding of how to negotiate for the public good.

Coming soon